سعر بيكوزيم حقن عضل/وريد 12 امبول 2024

Vitamin B-complex solution for i.m./i.v. injection, 2 ml ampoules, pack of 12 (imported Bayer product).

• Prevention of vitamin B deficiency during exclusive parenteral nutritionPopulation: Patients receiving exclusive parenteral nutritionBase de Données Publique des Médicaments (ANSM)

• Frequency not known: gastrointestinal pain, nausea, vomiting, constipation, diarrhoea; allergic reactions including anaphylactic reactions (e.g., asthma, rash, urticaria, facial oedema, pruritus); headache; chromaturia (urine discoloration due to vitamin B2); mild injection-site reactions.International label, same formulation · Base de Données Publique des Médicaments (ANSM)

• Hypersensitivity to the active substances or to any excipient (phenol, concentrated hydrochloric acid, water for injections).International label, same formulation · Base de Données Publique des Médicaments (ANSM)
• Combination with levodopa (see interactions).International label, same formulation · Base de Données Publique des Médicaments (ANSM)

• Do not exceed the recommended dose.International label, same formulation · Base de Données Publique des Médicaments (ANSM)
• The risk of hypersensitivity reactions is increased with repeated IM or IV injections; oral administration should be preferred whenever possible.International label, same formulation · Base de Données Publique des Médicaments (ANSM)
• Patients with severe renal impairment (GFR <30 mL/min) should consult a health professional before use.International label, same formulation · Base de Données Publique des Médicaments (ANSM)

• Levodopa (without a peripheral dopa-decarboxylase inhibitor)Pyridoxine inhibits the activity of levodopa used without a peripheral dopa-decarboxylase inhibitor; combination contraindicated - avoid any pyridoxine intake in the absence of such an inhibitor.Base de Données Publique des Médicaments (ANSM)
• Urobilinogen laboratory test (Ehrlich reagent)Vitamins B1 and B6 may cause false-positive results.Base de Données Publique des Médicaments (ANSM)

• Generally considered safe in pregnancy and breastfeeding at recommended doses, but controlled studies are lacking; use only when clinically indicated and recommended by a physician, without exceeding the recommended dose.International label, same formulation · Base de Données Publique des Médicaments (ANSM)
• The vitamins in Becozyme are excreted in breast milk; this should be taken into account during breastfeeding.International label, same formulation · Base de Données Publique des Médicaments (ANSM)

English text not available for this section.